Trial NCT04345991
Publication CORIPLASM - Lacombe K, Vox Sang (2022) (unpublished results)
Primary outcome on the report: The proportion of patients with WHO CPS greater than 5 on the 10-point scale on day 4 and survival without ventilation or additional immunomodulatory treatment by day 14

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.